Navigation Links
Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference
Date:5/21/2013

UNION CITY, Calif., May 21, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Martin Mulroy , chief commercial officer , will present at the Stifel Annual Dental & Veterinary Conference on Wednesday, May 29, 2013 at 11:30 a.m. ET. The conference will be held at Le Parker Meridien Hotel in New York City.

About Abaxis

Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.

Contact:    Clint Severson                                      Lytham Partners, LLC                       
                Chief Executive Officer                          Joe Dorame , Joe Diaz & Robert Blum            
                ABAXIS, Inc.                                        602-889-9700
                510-675-6500    


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
2. Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
3. Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference
4. Abaxis, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference
5. Abaxis, Inc. to Participate in Sidoti & Companys Inaugural One-on-One Conference
6. Abaxis, Inc. to Present at the Stephens Fall Investment Conference
7. Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
8. Abaxis, Inc. to Present at UBS Global Life Sciences Conference
9. Abaxis, Inc. to Present at CL Kings 10th Annual Best Ideas Conference 2012
10. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
11. Abaxis, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- Research and Markets has announced the addition ... report to their offering. ... Pain Management in the U.S.: ... physical pain, emphasizing consumer survey analysis, including trends over time. ... who have selected illnesses/conditions strongly associated with physical pain and ...
(Date:3/24/2017)... SHANGHAI , March 24, 2017 /PRNewswire/ ... organization providing high-quality and cost-effective drug development ... the pharmaceutical and biotechnology industry, announced today ... ShangPharma will be consolidating the ... Organizations (CMO) under Shanghai ChemPartner. These entities ...
(Date:3/24/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The IPF pipeline is very strong with a total of 97 drug ... Biogen and Sanofi are involved in the development of the IPF therapeutics. ... in Phase III stage, 15 are in Phase II stage, 12 are ...
Breaking Medicine Technology:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... How to Walk with God #TruthwithGrace”: a devotional journal chronicling the writer’s path ... to Learning How to Walk with God #TruthwithGrace” is the creation of published ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of ... college Bible teacher residing in North Carolina with his wife, Anna Marie. He and ... with six grandchildren. David is also the author of “Shadow and Substance.” , “Love, ...
(Date:3/24/2017)... ... , ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a ... to the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks ... pursuing her passion for writing, especially about truth and human behavior. , Published by ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... A recent ... for entry into teacher preparation programs. The NCTQ report suggests, based on a review ... requirements would significantly improve teacher quality in the U.S. It argues that this higher ...
(Date:3/23/2017)... Alexandria, Virginia (PRWEB) , ... March 23, 2017 ... ... quality public health services to their communities, 16 more public health departments have ... This week’s decisions bring another 4.5 million people into the expanding network of ...
Breaking Medicine News(10 mins):